187 related articles for article (PubMed ID: 21494766)
1. Interchangeability of generic anti-epileptic drugs: a quantitative analysis of topiramate and gabapentin.
Maliepaard M; Banishki N; Gispen-de Wied CC; Teerenstra S; Elferink AJ
Eur J Clin Pharmacol; 2011 Oct; 67(10):1007-16. PubMed ID: 21494766
[TBL] [Abstract][Full Text] [Related]
2. Interchangeability of generic drugs for subpopulations: Bioequivalence simulation from a nonparametric PK model of gabapentin generic drugs.
Glerum PJ; Yamada WM; Neely MN; Burger DM; Maliepaard M; Neef C
Br J Clin Pharmacol; 2024 Jul; 90(7):1576-1585. PubMed ID: 36482842
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioequivalence evaluation of two gabapentin preparations after a single oral dose in healthy Korean volunteers.
Cho HY; Kang HA; Lee YB
Int J Clin Pharmacol Ther; 2006 Aug; 44(8):386-92. PubMed ID: 16961169
[TBL] [Abstract][Full Text] [Related]
4. Interchangeability of gabapentin generic formulations in the Netherlands: a comparative bioavailability study.
Yu Y; Teerenstra S; Vanmolkot F; Neef C; Burger D; Maliepaard M
Clin Pharmacol Ther; 2013 Oct; 94(4):519-24. PubMed ID: 23708746
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of gabapentin in horses.
Dirikolu L; Dafalla A; Ely KJ; Connerly AL; Jones CN; ElkHoly H; Lehner AF; Thompson K; Tobin T
J Vet Pharmacol Ther; 2008 Apr; 31(2):175-7. PubMed ID: 18307511
[No Abstract] [Full Text] [Related]
6. Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
Odi R; Franco V; Perucca E; Bialer M
Epilepsia; 2021 Feb; 62(2):285-302. PubMed ID: 33426641
[TBL] [Abstract][Full Text] [Related]
7. Influence of caffeine on the protective activity of gabapentin and topiramate in a mouse model of generalized tonic-clonic seizures.
Jargiełło-Baszak M; Chrościńska-Krawczyk M; Andres-Mach M; Łuszczki JJ; Czuczwar SJ
Pharmacol Rep; 2016 Aug; 68(4):680-5. PubMed ID: 27116699
[TBL] [Abstract][Full Text] [Related]
8. Gabapentin synergistically interacts with topiramate in the mouse maximal electroshock seizure model: an isobolographic analysis.
Luszczki JJ; Czuczwar SJ
Pharmacol Rep; 2006; 58(6):944-54. PubMed ID: 17220554
[TBL] [Abstract][Full Text] [Related]
9. Comparative study on the bioequivalence of two different gabapentin formulations. A randomised, two-period, two-sequence, crossover clinical trial in healthy volunteers.
Almeida S; Filipe A; Almeida A; Antonijoan R; García-Gea C; Gich I; Barbanoj M; Cruz Caturla M
Arzneimittelforschung; 2006; 56(2):59-63. PubMed ID: 16572918
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence of single 100-mg doses of two oral formulations of topiramate: an open-label, randomized-sequence, two-period crossover study in healthy adult male Mexican volunteers.
Piñeyro-López A; Piñeyro-Garza E; Gómez-Silva M; Reyes-Araiza R; Flores-Diego MA; Borrego-Alvarado S; Gamino-Peña ME; Vargas-Zapata R; Salazar-Leal ME
Clin Ther; 2009 Feb; 31(2):411-7. PubMed ID: 19302913
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of gabapentin in a novel gastric-retentive extended-release formulation: comparison with an immediate-release formulation and effect of dose escalation and food.
Chen C; Cowles VE; Hou E
J Clin Pharmacol; 2011 Mar; 51(3):346-58. PubMed ID: 20484610
[TBL] [Abstract][Full Text] [Related]
12. [LC-MS/MS method for quantification and pharmacokinetic study of gabapentin in human plasma].
Xiong ZL; Yu J; He JF; Qin F; Li FM
Yao Xue Xue Bao; 2011 Oct; 46(10):1246-50. PubMed ID: 22242459
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with gabapentin and drugs affecting the renin-angiotensin system against electroconvulsions in mice.
Lukawski K; Janowska A; Jakubus T; Raszewski G; Czuczwar SJ
Eur J Pharmacol; 2013 Apr; 706(1-3):92-7. PubMed ID: 23500204
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of anticonvulsants in elderly patients with psychiatric disorders: oxcarbazepine, topiramate and gabapentin.
Sommer BR; Fenn HH; Ketter TA
Expert Opin Drug Saf; 2007 Mar; 6(2):133-45. PubMed ID: 17367259
[TBL] [Abstract][Full Text] [Related]
15. Determination of gabapentin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry.
Ji HY; Jeong DW; Kim YH; Kim HH; Yoon YS; Lee KC; Lee HS
Rapid Commun Mass Spectrom; 2006; 20(14):2127-32. PubMed ID: 16773671
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic effects of simultaneous administration of single-dose gabapentin 500 mg and zolpidem tartrate 10 mg in healthy volunteers: a randomized, open-label, crossover trial.
Galitz LA; Jayawardena S; Furey SA
Drugs R D; 2015 Mar; 15(1):71-7. PubMed ID: 25567214
[TBL] [Abstract][Full Text] [Related]
17. Relative bioavailability study with two oral formulations of topiramate using a validated UPLC-MS/MS method.
Saavedra I; Tamayo E; Gamboa A; Sasso J; Varela N; Moreno I; Marchant D; Cáceres D; Quiñones L
Int J Clin Pharmacol Ther; 2010 May; 48(5):342-8. PubMed ID: 20420791
[TBL] [Abstract][Full Text] [Related]
18. The effect of MDR1 G2677T/A polymorphism on pharmacokinetics of gabapentin in healthy Korean subjects.
Kang HA; Cho HY; Lee YB
Arch Pharm Res; 2007 Jan; 30(1):96-101. PubMed ID: 17328248
[TBL] [Abstract][Full Text] [Related]
19. [Bioequivalence and generics of index drugs with narrow therapeutic margins].
Le Corre P
Presse Med; 2010 Feb; 39(2):169-76. PubMed ID: 19932591
[TBL] [Abstract][Full Text] [Related]
20. Single dose pharmacokinetic equivalence study of two gabapentin preparations in healthy subjects.
Tjandrawinata RR; Setiawati E; Putri RS; Yunaidi DA; Amalia F; Susanto LW
Drug Des Devel Ther; 2014; 8():1249-55. PubMed ID: 25214768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
